SCHEMBL1270979

SCHEMBL1270979

O/N=C\c1ccnc(O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HTT P42858 1/20 0.37
ALOX15 P16050 1/20 0.37
RIPK1 Q13546 2/20 0.36
KMT2A Q03164 2/20 0.35
ACHE P22303 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
POLB P06746 2/20 0.33
ALPL P05186 1/20 0.33
ALPI P09923 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11885260 1.00 L3MBTL1 (0.42) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL1270980 1.00 L3MBTL1 (0.42) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL21866491 0.79 L3MBTL1 (0.51) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL21866490 0.79 L3MBTL1 (0.51) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL14022341 0.78 KDM1A (0.46) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL10666814 0.78 RECQL (0.42) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL436495 0.78 ALDH1A1 (0.41) L3MBTL1ALDH1A1KDM4EALOX15RIPK1
SCHEMBL469111 0.78 ALDH1A1 (0.41) L3MBTL1ALDH1A1KDM4EALOX15RIPK1
SCHEMBL14662457 0.78 KDM1A (0.46) L3MBTL1ALDH1A1KDM4EHTTALOX15
SCHEMBL11890232 0.78 UHRF1 (0.45) L3MBTL1ALDH1A1KDM4EHTTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227617-B2 Process for preparing 2-hydroxy-4-substituted pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2012-07-24 US claimed
US-20110034697-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., INC. (JP) 2011-02-10 US claimed
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines YUKI GOSEI KOGYO CO., INC. (JP) 2008-11-20 US claimed
EP-1801102-A1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., LTD. (JP) 2007-06-27 EP claimed
US-8227617-B2 Process for preparing 2-hydroxy-4-substituted pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2012-07-24 US disclosed
US-8227234-B2 Process for preparing 2-hydroxy-4-substituted pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2012-07-24 US disclosed
EP-1801102-B1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI YAKUHIN KOGYO KK (JP) 2011-09-07 EP disclosed
US-20110034697-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., INC. (JP) 2011-02-10 US disclosed
US-20110027864-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., INC. (JP) 2011-02-03 US disclosed
US-7803585-B2 Process for preparing 2-Hydroxy-4-Substituted Pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2010-09-28 US disclosed
US-7803585-B2 Process for preparing 2-Hydroxy-4-Substituted Pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2010-09-28 US disclosed
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines YUKI GOSEI KOGYO CO., INC. (JP) 2008-11-20 US disclosed
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines YUKI GOSEI KOGYO CO., INC. (JP) 2008-11-20 US disclosed
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines YUKI GOSEI KOGYO CO., INC. (JP) 2008-11-20 US disclosed
EP-1801102-A1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., LTD. (JP) 2007-06-27 EP disclosed
EP-1801102-A1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., LTD. (JP) 2007-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines BPGM, CYP4F11, CYP4F2 L3MBTL1 2267/4885ALDH1A1 861/4885KDM4E 53/4885
US-20110034697-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES HPD, CYP4X1, CYP4B1 L3MBTL1 4784/4885ALDH1A1 697/4885KDM4E 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.